Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Harvard Bioscience (HBIO) Short-Term Debt issuances (2021 - 2024)

Historic Short-Term Debt issuances for Harvard Bioscience (HBIO) over the last 4 years, with Q3 2024 value amounting to $3.2 million.

  • Harvard Bioscience's Short-Term Debt issuances rose 22500.0% to $3.2 million in Q3 2024 from the same period last year, while for Jun 2025 it was $3.2 million, marking a year-over-year decrease of 5695.36%. This contributed to the annual value of $8.8 million for FY2024, which is 9555.56% up from last year.
  • Latest data reveals that Harvard Bioscience reported Short-Term Debt issuances of $3.2 million as of Q3 2024, which was up 22500.0% from $3.0 million recorded in Q2 2024.
  • In the past 5 years, Harvard Bioscience's Short-Term Debt issuances registered a high of $3.8 million during Q2 2022, and its lowest value of $1.0 million during Q2 2023.
  • For the 4-year period, Harvard Bioscience's Short-Term Debt issuances averaged around $2.1 million, with its median value being $2.1 million (2021).
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first plummeted by 7368.42% in 2023, then surged by 22500.0% in 2024.
  • Quarter analysis of 4 years shows Harvard Bioscience's Short-Term Debt issuances stood at $1.8 million in 2021, then skyrocketed by 42.86% to $2.5 million in 2022, then crashed by 60.0% to $1.0 million in 2023, then surged by 225.0% to $3.2 million in 2024.
  • Its Short-Term Debt issuances was $3.2 million in Q3 2024, compared to $3.0 million in Q2 2024 and $2.5 million in Q1 2024.